Skip to main content
. 2012 Mar 17;2(1):1. doi: 10.1007/s13555-012-0001-y

Fig. 7.

Fig. 7

Final results of the voting on case scenario 6, severe scalp psoriasis that is unresponsive to topical therapy. a denotes P < 0.05 compared with TNFI-adalimumab preferred therapy; b denotes P < 0.05 compared with adalimumab therapy. MTX methotrexate; pref preferred; TNFI tumor necrosis factor inhibitor